digital therapeutics
2022 Look Ahead
Pharma companies continue to team up with startups and invest in AI for drug discovery.
Healthcare professionals other than physicians, dentists and veterinarians who have prescribing authority under state law can order prescription digital therapeutics. That could improve access, especially to devices that treat mental health conditions.
The digital therapeutics industry must conduct and publish rigorous, replicable research if it is to truly become a legitimate option alongside in-person cognitive behavioral therapy and medications.
'HelloBetter Stress and Burnout', Germany’s digital therapeutic program, is now free of charge to those insured by statutory health insurance.
They will develop and commercialise three novel digital therapeutic products.
Armin Scheuer, VP of Business Development International at HIMSS, says Germany is prescribing apps to patients within their normal care setting, in the form of DiGAs, and France has decided to replicate the system.
More than five million adults will be able to access to CBT through Big Health’s apps.
There are many stakeholders interested in digital therapeutics, but aligning under the common goal of patient needs is key.
The app provides personalised treatment guidance to users based on their BP record, habit logs and behavioural changes.
The company is working with the Mayo Clinic on a tool called Neuroglee Connect.